Home

Daphne Karydas, Director: Mineralys Therapeutics MLYS Sell · Filed 25/11/13

Trade details

Type
Insider sale
Amount
$463,368.15
Shares · price
10,115 sh · $45.81 a share
Held after
4,885 sh
Trade date
25/11/13
Filed
25/11/13
Days to filing
0 days

Sold 67.4% of holdings

Share of holding sold
67.4%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/14~25/12/13

Daphne Karydas's recent trades

  • Daphne Karydas

    Planned sale10b5-1 planMineralys Therapeutics

    $85.7K

    Filed 09/15

  • Daphne Karydas

    Sell10b5-1 planMineralys Therapeutics

    $75K

    Filed 06/17

  • Daphne Karydas

    Planned sale10b5-1 planMineralys Therapeutics

    $75K

    Filed 06/17

  • Daphne Karydas

    Sell10b5-1 planMineralys Therapeutics

    $75K

    Filed 04/02

  • Daphne Karydas

    Planned sale10b5-1 planMineralys Therapeutics

    $75K

    Filed 03/31

Daphne Karydas, Director — sold $463.4K of Mineralys Therapeutics MLYS · 67.4% of holdings | Whalegun